A EUROPEAN LEADER IN PHARMACEUTICAL PRODUCTS FOR THE CENTRAL NERVOUS SYSTEM (CNS)
With a unique understanding of the CNS market for over 35 years, Neuraxpharm develops and commercializes value added medicines, standard generics, medical cannabis and Consumer Healthcare products, e.g. nutraceuticals and probiotics in Europe.
We are continuously striving to offer a wide range of effective, high quality and affordable CNS treatments aimed at patients as well as health professionals and industry partners.
Additionally, through our manufacturing companies Lesvi and Inke, Neuraxpharm has an international presence in more than 50 countries. We provide industry partners with finished dosage forms (FDFs) across multiple technologies and niche active pharmaceutical ingredients (APIs) using our expertise in the CNS and the respiratory areas.
NEURAXPHARM, SPECIALIZED IN CNS SINCE 1985
NEURAXPHARM GROUP
Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals and nutraceuticals for the treatment and prevention of CNSdisordersin main European countries
B2B solutions provider dedicated to the development and manufacturing of finished dosage forms (FDFs)
The consolidation of all the companies within Neuraxpharm allows us to establish growth and cross-business operational synergies in strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion
is a subsidiary of
